Japan’s Theravalues Clinical Trial Claims Curcumin Benefits For Common Cold
Executive Summary
Japanese curcumin specialist Theravalues claims to have found via a randomized clinical trial that its Theracurmin and Theracurmin Super dietary supplements can help alleviate some symptoms of the common cold. “However, the level of evidence is weak,” they warn. “Additionally, because the study was based on the reporting of subjective cold-like symptoms, it is was unclear whether the symptoms were actual subjective symptoms caused by an upper respiratory tract infection.”
You may also be interested in...
French Authority Asks For More Data On Turmeric Supplements After Hepatitis Cases Reported
Following reports of side-effects linked to turmeric supplement use in France and Italy, the former's Agency for Food, Environmental and Occupational Health & Safety (ANSES) is asking manufacturers selling turmeric supplements in the country to provide additional bioavailability data. ANSES is concerned that new formulations are pushing consumers over the recommended daily intake limit set by the European Food Safety Authority.
Curcumin Touted For Oral Health Gets EFSA Novel Food Nod
In its latest batch of novel food assessments, the European Food Safety Authority gave the nod to a curcumin supplement touted for its oral health benefits, but rejected applications for flowering plant Tongkat Ali and water lentil Wolffia globosa.
Why Are UK CBD Brands Pivoting Into Functional Mushroom Supplements?
Ongoing regulatory issues and restrictive marketing rules are prompting CBD brands to pivot to functional mushrooms, the market for which in the UK is predicted to reach a value of £62m by 2025. With both reportedly offering cognitive health benefits, marketing mushrooms and CBD makes good strategic sense, explains Nootro Group CEO Cary Holmes in this HBW Insight deep dive.